Guadalquiver, Jezza L.
HRN: 25-25-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2024
AMPICILLIN 1GM (VIAL)
06/05/2024
06/07/2024
IV
2grams
Q6hrs
G1P0, Leaking BOW
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes